Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.

Jin Soon Hwang; Hae Sang Lee; Woo Yeong Chung; Heon-Seok Han; Dong-Kyu Jin; Cheol-Woo Ko; Byung-Churl Lee; Dae-Yeol Lee; Kee-Hyoung Lee; Jeh-Hoon Shin; Byung-Kyu Suh; Han-Wook Yoo; Hyi-Jeong Ji; Jin-Hwa Lee; Yoon Ju Bae; Duk-Hee Kim; Sei Won Yang

Purpose: The purpose of this study was to investigate the efficacy and safety of LB03002, a sustainedrelease human GH (SR-hGH), compared with that of daily rhGH for 12 months in children with GH deficiency (GHD). Methods: A total of 73 children with GHD were screened and 63 eligible subjects were randomized in a 1:1 ratio of LB03002 (SR-hGH) to daily rhGH treatment group. LB03002 was administered once weekly at a dose of 0.5 mg/kg while daily rhGH was administered for 6 consecutive days with equally divided doses to make a total of 0.21 mg/kg per week. Treatments were given for 12 months by s.c. injections. Injection site reactions and adverse events were investigated throughout the study period. Results: The mean (S.D.) height velocity (HV) showed a clinically significant increase after the 6-month treatment: 3.00 (1.15) cm/year at screening to 9.78 (1.98) cm/year at 6 months in the LB03002 group; 2.39 (1.63) cm/year at screening to 10.56 (2.65) cm/year at 6 months in the daily rhGH group. The increased HVat 12 months was still maintained in both the groups: 9.06 (1.63) cm/year at 12 months in the LB03002 group; 9.72 (2.32) cm/year at 12 months in the daily rhGH group. Most of the adverse drug reactions were mild and tolerable. No subjects were withdrawn due to adverse events. Conclusion: Weekly injection of LB03002 at a dose of 0.5 mg/kg per week was confirmed to have comparable efficacy to daily injection of rhGH at a dose of 0.21 mg/kg per week. Both formulations were well tolerated.

DRUG efficacy; INJECTIONS; STANDARD deviations; IDIOSYNCRATIC drug reactions; CLINICAL medicine research; DRUG side effects; SAFETY

European Journal of Endocrinology, 2013, Vol 169, Issue 2, p179

0804-4643

Academic Journal

10.1530/EJE-13-0148